中图分类号:
R917
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] HUANG B, LI G, GUO Y F, et al. Study on absorption location of four components from Naoxintong capsule. Chin J Chin Mater Med(中国中药杂志), 2013,38(6):889-893.
[2] ZHAO T, ZHAO B C, WU H Q, et al. The role research of Naoxintong capsule in cardio-cerebrovascular disease. J Tradit Chin Med(中医杂志), 2012,53(24):2150-2152.
[3] WANG C J, SUN B G, ZHANG J, et al. Determination of the content of paeoniflorin in Naoxintong Capsules by HPLC. Qilu Pharm Aff(齐鲁药事), 2006,25(3):153-155.
[4] SUN L L, WANG M, REN X L. Application progress on chemical pattern recognition in quality control of Chinese materia medica. Chin Tradit Herb Drugs(中草药),2017,48(20):4339-4345.
[5] CHEN J S, WANG Z Y, CHEN Q H. Determination of protocatechu aldehyde in Naoxintong capsule by HPLC. Guid J Tradit Chin Med Pharm(中医药导报),2015,21(22):34-36.
[6] LI G, MENG F Y, YANG H J, et al. UPLC simultaneous determination of five components in Naoxintong capsules. J Pharm Anal(药物分析杂志),2013,33(3):414-418.
[7] ZHANG H L, CUI Y X, WANG S M, et al. Determination of paeoniflorin in Naoxintong capsules by HPLC. China J Chin Med(中医学报),2010,25(1):118-119.
[8] ZHANG Y C. The content determination of tanshinoneII A in Buchang Naoxintong capsule . Liaoning J Tradit Chin Med(辽宁中医杂志),2008,35(4):590.
[9] SU H, HE J B, HOU P H, et al. HPLC fingerprint study and component content determination in Naoxintong capsule. Hebei Med J(河北医药),2015,37(5):764-767.
[10] WANG S M, HOU X J, ZHANG Y. Molecular mechanism of immunological escape in tumor and multiple targets of Chinese herbal drugs. Shaanxi J Tradit Chin Med(陕西中医),2003,24(9):836-837.
[11] SUN Z, HOU P Y, ZHOU L, et al. Quantitative research of multiple active components in Yixinshu Tablet based on ultra performance liquid chromatography-quadrupole/orbitrap high resolution mass spectrometry. Chin Tradit Herb Drugs(中草药),2017,48(10):1977-1982.
[12] WU W J, ZHOU W E, ZHANG Y, et al. The achievements of LC-MS/MS for the analytical phytochemicals of traditional Chinese medicines. Lishizhen Med Mater Med Res(时珍国医国药),2016,27(11):2735-2737.
[13] ZHANG Y, DONG W T, HUO J H, et al. Analysis on chemical constituents of Pheretima aspergillum by UPLC-Q-TOF-MS. Chin Tradit Herb Drugs(中草药),2017,48(2):252-262.
[14] Showing metabocard for 4-Hydroxycinnamic acid (HMDB0002035) . Human Metabolome Database: http://www. hmdb. ca/metabolites/HMDB0002035.
[15] Showing metabocard for Phthalic acid (HMDB0002107) . Human Metabolome Database:http://www.hmdb.ca/metabolites/HMDB0002107
[16] ZHAO H Z, WANG J, JIANG M, et al. UPLC fingerprint and qualitative analysis study on salvia total phenolic acids. J Pharm Anal(药物分析杂志),2012,32(4):620-622.
[17] SHU P, HONG J L,WU G, et al. Analysis of flavonoids and phenolic acids in Iris tectorum by HPLC-DAD-ESI-MSn. Chin J Nat Med(中国天然药物),2010,8(3):202-207.
[18] SHU Y, SU S L, QIAN D W, et al. Chemical composition of Rougan Capsule by UPLC-ESI-QTOF/MS. Chin Tradit Pat Med(中成药),2011,33(1):73-78.
[19] LIU J, YANG H J, LI X C, et al. Analysis of diterpene quinones in Danshen (Salvia miltiorrhiza Bunge) by HPLC-ESI/TOFMS. J Chin Mass Spectromet Soc(质谱学报),2008,29(5):262-267.
[20] CHU Y T, WEI W F, HUO J H, et al. Analysis of chemical constituents in Qinbai Qingfei Concentrated Pills by UPLCQ-TOF-MS. Chin Tradit Pat Med(中成药),2016,36(6):1303-1310.
[21] Spectrum 120_30_iTree_NEG_08252014_26 for arachidic acid , MassBank of North America: http://mona.fiehnlab.ucdavis.edu/spectra/display/120_30_iTree_NEG_08252014_26.
[22] HASHIMOTO M, SUZUKI T, IWASHINA T. New acylated anthocyanins and other flavonids from the flowers of clematis cultivars.Nat Prod Comun,2011,6(11):1631-1636.
[23] LI H, WAN L R, WANG H, et al. Identification and mass spectrometric characterization of isomeric isoflavone aglycones by ESI-IT-TOF mass spectrometry. Chem J Chin Univ(高等学校化学学报),2007,28(12):2284-2289.
[24] DONG J, WANG H, WAN L R, et al. Identification and determination of major constituents in Polygonum cuspidatum Sieb. et Zucc. by high performance liquid chromatography/electrospray ionization-ion traptime-of-flight mass spectrometry. Chin J Chromatogr(色谱),2009,27(4):425-430.
[25] GUO D, HUO J H, CHENG T, et al. Identification and characterization of chemical constituents in leaves of Juglans mandshurica based on UPLC-Q-TOF/MS. Chin Med Mat(中药材),2017,40(5):1124-1130.
[26] WU J Y, GAO F Y, YE X L, et al. Chuan'agelei and its flatten structure ferulic and ligustrazine:mass fragmentation pathway. Acad J Second Mil Med Univ(第二军医大学学报),2017,33(7):755-758.
[27] XUAN W. The research progress of flavonoids compounds. Forest By-Product and Spe China(中国林副特产),2017,146(1):66-69.
[28] JIAO J J, ZHANG Y. The latest research on flavonoids in the prevention and treatment of diabetes mellitus and its complications in progress. Chin Pharm J(中国药学杂志),2006,41(7):481-484.
[29] WEI L. Research and practice of Chinese medicines. Res Pract Chin Med(现代中药研究与实践),2013,27(1):34-35.
[30] LU X H, MA X, WANG J, et al. Research progress on chemical constituents of Paeoniae Rubra Radix and their pharmacological effects. Chin Tradit Herb Drugs(中草药),2015,46(4):595-602.
[31] TANG X L, LIU J X, LI L. Pharmacological effects of organic acids in Chinese herbs and its application in cardiovascular diseases. Chin J Exp Tradit Med Form(中国实验方剂学杂志),2012,18(5):243-246.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
河南省高等学校重点科研项目基础研究计划资助(19A320070);常州四药临床药学科研基金资助(CZSYJJ6015);河南省科技计划项目资助(182102310243)
{{custom_fund}}